2013 Fiscal Year Final Research Report
A study of gene polymorphism related to drug-induced lung disease
| Project/Area Number |
23591143
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Shinshu University |
|---|
Principal Investigator |
KUBO Keishi 信州大学, 医学部, 特任教授 (80143965)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HANAOKA Masayuki 信州大学, 医学部, 教授 (20334899)
OTA Masao 信州大学, 医学部, 准教授 (50115333)
ITO Michiko 信州大学, 医学部附属病院, 助教 (60569812)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 遺伝子 / ゲノム / 薬剤性肺障害 |
|---|
| Research Abstract |
In this study, we investigated genetic background in patients with drug-induced lung disease, which has displayed an increasing trend in recent years. Upon considering gene polymorphism in patients with drug-induced lung disease for the purpose of early diagnosis, there were multiple relationships between gene polymorphism and the disease. Going forward, by means of the accumulation of an additional number of cases and genetic functional analysis, an even clearer understanding of the clinical conditions of drug-induced lung damage can be expected.
|
Research Products
(12 results)
-
-
-
-
-
-
[Journal Article] Consensus statement for the diagnosis and treatment of drug-induced lung injuries2013
Author(s)
Kubo K, Azuma A, Kanazawa M, Kameda H, Kusumoto M, Genma A, Saijo Y, Sakai F, Sugiyama Y, Tastumi K, Dohi M, Tokuda H, Hashimoto S, Hattori N, Hanaoka M, Fukuda Y
-
Journal Title
Respir Invest
Volume: 51巻
Pages: 260-277
DOI
Peer Reviewed
-
-
-
-
-
-
